Terns Pharmaceuticals, Inc. (NASDAQ: TERN) reported Q2 EPS of ($0.25), $0.08 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Terns Pharmaceuticals, Inc. (TERN) click here.